Outset Medical, Inc. reported unaudited revenue for the fourth quarter and fiscal year ended December 31, 2025.
Revenue in the fourth quarter totaled approximately $28.9 million, with total revenue for 2025 reaching approximately $119.5 million, a 5% increase over 2024.
Karen N. Prange, a medical technology veteran, has been appointed to Outset Medical's board of directors.
Revenue Growth
Total revenue for 2025 increased by 5% compared to the previous year, reaching around $119.5 million.
Expansion of Sites of Care
Over 1,000 sites of care have insourced dialysis with Outset by the end of 2025, performing approximately 1 million treatments per year.
Financial Position
Year-end cash, including restricted cash and cash equivalents, totaled $173 million, with net cash used in operations reduced significantly compared to 2024.
New Board Member
Karen N. Prange, with extensive experience in medical technology, joins Outset Medical's board of directors, bringing valuable expertise to the company.
- Outset Medical's revenue growth in 2025 showcases continued success in the medical technology sector.
- The addition of Karen N. Prange to the board of directors enhances Outset's leadership with her deep industry knowledge and experience.
Outset Medical enters 2026 with a strong financial position and a promising outlook for growth, driven by innovation and strategic appointments like Karen N. Prange to the board of directors.